Mediplantex National Pharmaceutical JSC (HNX:MED)

HNX:MED Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 29, 2026	Dec 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021
Market Capitalization	253,164	291,635	322,660	335,070	260,610	187,775
Market Cap Growth	55.05%	-9.62%	-3.70%	28.57%	38.79%	-23.33%
Enterprise Value	255,977	312,499	332,302	335,404	170,199	147,414
Last Close Price	20400.00	23500.00	24660.94	24749.42	18879.37	26565.12
PE Ratio	16.57	19.10	21.16	28.53	40.94	50.11
PS Ratio	0.69	0.79	0.73	0.83	0.65	0.55
PB Ratio	0.77	0.88	0.98	1.02	0.81	1.13
P/TBV Ratio	0.77	0.88	0.98	1.02	0.81	1.13
P/FCF Ratio	-	-	8.57	-	-	24.24
P/OCF Ratio	-	-	6.77	-	9.94	3.02
EV/Sales Ratio	0.70	0.85	0.75	0.83	0.42	0.43
EV/EBITDA Ratio	9.00	10.99	11.04	14.83	9.12	8.00
EV/EBIT Ratio	12.12	14.80	14.97	23.65	19.71	16.58
EV/FCF Ratio	-12.70	-	8.82	-	-	19.03
Debt / Equity Ratio	0.10	0.10	0.08	0.20	0.28	0.41
Debt / EBITDA Ratio	1.19	1.19	0.92	2.85	4.87	3.72
Debt / FCF Ratio	-	-	0.74	-	-	8.86
Asset Turnover	0.76	0.76	0.84	0.64	0.67	0.68
Inventory Turnover	3.13	3.13	3.68	3.12	3.38	3.05
Quick Ratio	0.56	0.56	0.73	0.69	0.83	0.70
Current Ratio	1.62	1.62	1.46	1.32	1.22	1.04
Return on Equity (ROE)	4.62%	4.62%	4.63%	3.62%	2.61%	2.16%
Return on Assets (ROA)	2.75%	2.75%	2.62%	1.41%	0.91%	1.09%
Return on Invested Capital (ROIC)	4.76%	5.07%	5.51%	3.93%	3.35%	4.09%
Return on Capital Employed (ROCE)	6.40%	6.40%	6.70%	4.30%	2.70%	5.40%
Earnings Yield	6.03%	5.24%	4.72%	3.50%	2.44%	2.00%
FCF Yield	-7.96%	-6.91%	11.68%	-25.22%	-34.93%	4.13%
Dividend Yield	3.60%	-	-	3.64%	2.65%	0.94%
Payout Ratio	65.38%	65.38%	72.28%	54.72%	138.49%	354.43%
Buyback Yield / Dilution	0.03%	0.03%	-	-32.18%	-49.59%	0.05%
Total Shareholder Return	3.63%	0.03%	-	-28.54%	-46.94%	0.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.